StartupsFinSMEsabout 2 hours ago
Tikva Allocell Raises $8M in Series A Funding
1 min read
Tikva Allocell raised $8 million in Series A funding. The round supports the company's work in developing allogeneic cell therapies for solid tumors. The funding will advance preclinical programs and platform development.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
